SDEV Insider Trading - Stablecoin Development Corporation

Ausstehende Aktien	49,779,686 shares
Insider-Aktien	36.439.665 shares
Insider-Besitz	73,20 %
Insider gesamt	49

Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Siehe Aktien mit dem höchsten Ranking

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Siehe Aktien mit dem höchsten Ranking

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

0 ( )

683 out of 10951

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

0.000% ( )

696 out of 10791

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

Stablecoin Development Corporation Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktien in Besitz	Split Angepasst
Mark Brian Anderson CSO - [O]	100	4
Keith R Bley	258.120
Charles Cashion Director - [D]	18.495	740
China Pioneer Pharma Holdings Ltd 10% Owner - [10%]	426.984	17.079
Anthony Dailley Director - [D]	285.259	11.410
Framework Ventures IV L.P. 10% Owner - [10%]	11.361.216	11.361.216
Freiman Paul E. Director - [D]	1.783	89
Jian Ping Fu 10% Owner - [10%]	4.000.000	160.000
Julie Garlikov Director - [D]	858	43
Justin Hall CEO, GC and Director, Director - [D] [O]	83.172	3.327
Hoon Russell A. Senior Vice President - [O]	34.217	1.369
Jones Andrew D. CFO - [O]	127.461	5.098
Michael John Kazley Chief Executive Officer, Director, 10% Owner - [D] [O] [10%]	11.361.216	11.361.216
Behzad Khosrovi VP, Research & Dev't - [O]	135.000	5.400
Audrey Kunin Chief Product Officer - [O]	0	0
Jeffrey Kunin President, DERMAdoctor, LLC - [O]	0	0

Insider	Aktien in Besitz	Split Angepasst
Xiaoyan Liu Director - [D]	0	0
Tommy Law Interim CFO - [O]	0	0
Lazar David E. 10% Owner - [10%]	6.388.000	1.277.600
Xinzhou Li 10% Owner - [10%]	2.001.743	80.070
Yanbin Liu Director - [D]	0	0
Yonghao Ma Director - [D]	0	0
Gail J Maderis	20.000
John Joseph McGovern CFO and Treasurer - [O]	0	0
McPherson T. Alex Director - [D]	28.558	1.142
Naqu Area Pioneer Pharma Co., Ltd. 10% Owner - [10%]	800.000	32.000
Najafi Family Trust dated September 13, 2006 10% Owner - [10%]	3.117.500	124.700
Ramin Najafi Chief Executive Officer, Director, 10% Owner - [D] [O] [10%]	12.000	480
Thomas J Paulson CFO - [O]	142.196	5.688
Poplar Point Capital Partners Lp 10% Owner - [10%]	754.102	150.820
Pharma (Hong Kong) Co Ltd Pioneer 10% Owner - [10%]	5.188.421	207.537
Pioneer Pharma (Singapore) Pte. Ltd. 10% Owner - [10%]	5.188.421	207.537

Insider	Aktien in Besitz	Split Angepasst
R01 Fund LP 10% Owner - [10%]	11.361.216	11.361.216
Massimo Radaelli	2.400
Jason Philip Raleigh Interim CFO and Treasurer - [O]	0	0
Mark M Sieczkarek -	1.156.883	46.275
Lewis J Stuart Chief Commercial Officer - [O]	0	0
Colin Scott	72.900
Swan Sit Director - [D]	1.716	86
Stroman David W. SVP, Ophthalmic Product Devt. - [O]	23.000	920
Tufts Robert R. Director - [D]	348.408	13.936
Mijia Wu Director - [D]	1.716	86
Roy J Wu SVP Bus & Corp Development - [O]	19.296	772
Xiaopei Wang Director - [D]	0	0
Wicks Tony D.S. Director - [D]	0	0
Wang Xu NEO - Sr Mgr and Controller - [O]	42.000	1.680
Todd Erik Zavodnick Director - [D]	0	0
Yenyou Zheng Director - [D]	1.716	86
Yongxiang Zheng Director - [D]	858	43

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in SDEV / Stablecoin Development Corporation getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum	Insider	Gemeldete Aktien	Gemeldeter Preis	Angepasste Aktien	Angepasster Preis	Kostenbasis	Tage bis Max	Preis bei Max	Max Gewinn ($)	Max Rendite (%)
2025-04-08	POPLAR POINT CAPITAL PARTNERS LP	300	0,4650	60	2,3250	140	276	19.1600	1.011	727,05
2025-04-04	POPLAR POINT CAPITAL PARTNERS LP	4.538	0,5216	908	2,6080	2.367
2025-04-03	POPLAR POINT CAPITAL PARTNERS LP	22.976	0,5627	4.595	2,8135	12.929
2025-04-02	POPLAR POINT CAPITAL PARTNERS LP	917	0,5800	183	2,9000	532
2025-04-01	POPLAR POINT CAPITAL PARTNERS LP	19.915	0,5850	3.983	2,9250	11.650
2025-03-31	POPLAR POINT CAPITAL PARTNERS LP	21.654	0,5900	4.331	2,9500	12.776
2025-03-28	POPLAR POINT CAPITAL PARTNERS LP	49.400	0,6124	9.880	3,0620	30.253
2025-03-27	POPLAR POINT CAPITAL PARTNERS LP	18.504	0,6150	3.701	3,0750	11.380
2025-03-27	POPLAR POINT CAPITAL PARTNERS LP	600	0,6090	120	3,0450	365

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

SDEV / Stablecoin Development Corporation Insider Trades

Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in SDEV / Stablecoin Development Corporation. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum	Insider	Gemeldete Aktien	Gemeldeter Preis	Angepasste Aktien	Angepasster Preis	Kostenbasis	Tage bis Min	Preis bei Min	Max Verlust Vermieden($)	Max Verlust Vermieden(%)
2022-12-06	Kunin Audrey	1	1,8100	0	36,2000	2	363	10.15	-1	-100,00
2022-12-06	Kunin Jeffrey	1	1,8100	0	36,2000	2
2022-11-21	Kunin Audrey	5.960	2,1049	298	42,0980	12.545
2022-11-21	Kunin Jeffrey	5.960	2,1049	298	42,0980	12.545
2022-11-21	Kunin Audrey	5.960	2,1049	298	42,0980	12.545
2022-11-21	Kunin Jeffrey	5.960	2,1049	298	42,0980	12.545
2022-09-14	Kunin Audrey	291.368	0,1582	11.655	3,9550	46.094
2022-09-14	Kunin Jeffrey	291.368	0,1582	11.655	3,9550	46.094
2020-08-17	WU MIJIA	20.000	1,3500	800	33,7500	27.000

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei Datum	Handel Datum	Form	Insider	Ticker	Wertpapier-Titel	Code	Direkt	Ausführung Preis	Einheit Preis	Eimheiten Verändert	Wert Geändert (1K)	Verbleibende Optionen	Verbleibende Aktien
2026-04-30	2025-10-21	4/A	Kazley Michael John By R01 Entities	SDEV	Common Stock	C - Conversion	I			11.361.216			11.361.216
2026-04-30	2025-10-21	4/A	Framework Ventures IV L.P.	SDEV	Common Stock	C - Conversion	D			11.361.216			11.361.216
2026-04-30	2025-10-21	4/A	R01 Fund LP	SDEV	Common Stock	C - Conversion	D			11.361.216			11.361.216
2026-01-29	2025-10-21	4	Lazar David E.	NBY	Common Stock	A - Award	D			6.388.000			6.388.000
2025-11-03	2025-10-21	4	Kazley Michael John By R01 Entities	NBY	Common Stock	C - Conversion	I			56.806.080			56.806.080
2025-11-03	2025-10-21	4	R01 Fund LP	NBY	Common Stock	C - Conversion	D			56.806.080			56.806.080
2025-11-03	2025-10-21	4	Framework Ventures IV L.P.	NBY	Common Stock	C - Conversion	D			56.806.080			56.806.080
2025-08-26		3	Lazar David E.	NBY	Common Stock		D						0
2025-04-15	2025-04-08	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,4650	300	0		1.020.300
2025-04-15	2025-04-04	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5216	4.538	2		1.020.000
2025-04-15	2025-04-03	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5627	22.976	13		1.015.462
2025-04-15	2025-04-02	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5800	917	1		992.486
2025-04-15	2025-04-01	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5850	19.915	12		991.569
2025-04-15	2025-03-31	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5900	21.654	13		971.654
2025-04-15	2025-03-28	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6124	49.400	30		950.000
2025-04-15	2025-03-27	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6090	600	0		900.600
2025-04-15	2025-03-27	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6150	18.504	11		900.000
2025-04-15	2025-03-26	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6090	13.292	8		881.496
2025-04-15	2025-03-25	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6100	22.635	14		868.204
2025-04-15	2025-03-24	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6050	100	0		845.569
2025-04-15	2025-03-21	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6050	6.372	4		845.469
2025-04-15	2025-03-20	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6149	5.320	3		839.097
2025-04-15	2025-03-19	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6025	1.500	1		833.777
2025-04-15	2025-03-18	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6300	14.000	9		832.277
2025-04-15	2025-03-18	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6300	10.000	6		818.277
2025-04-15	2025-03-14	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6300	25.511	16		808.277
2025-04-15	2025-03-13	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6350	34	0		782.766
2025-04-15	2025-03-12	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6226	11.837	7		782.732
2025-04-15	2025-03-11	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5800	2.148	1		770.895
2025-04-15	2025-03-10	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5800	14.645	8		768.747
2025-04-15	2025-03-07	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5500	102	0		754.102
2025-04-15	2025-03-04	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,5784	4.000	2		754.000
2025-04-15	2025-02-28	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6020	13.108	8		750.000
2025-04-15	2025-02-27	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6100	385	0		736.892
2025-04-15	2025-02-26	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6100	6.302	4		736.507
2025-04-15	2025-02-25	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6199	25.033	16		730.205
2025-04-15	2025-02-24	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6200	450	0		705.172
2025-04-15	2025-02-20	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6300	1.836	1		704.722
2025-04-15	2025-02-19	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6715	49.664	33		702.886
2025-04-15	2025-02-18	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6600	3.222	2		653.222
2025-04-15	2025-02-04	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6350	26.718	17		650.000
2025-04-15	2025-02-03	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6350	2.597	2		623.282
2025-04-15	2025-01-31	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6483	70.685	46		620.685
2025-04-15	2025-01-27	4	POPLAR POINT CAPITAL PARTNERS LP	NBY	Common Stock, par value $0.01 per share	P - Purchase	D		0,6900	31.703	22		550.000
2025-04-07		3	POPLAR POINT CAPITAL PARTNERS LP	NBY	COMMON STOCK, PAR VALUE $0.01		D						518.297
2023-05-15	2023-05-11	4	Freiman Paul E.	NBY	Common Stock	M - Exercise	D			858			1.716
2023-05-15	2023-05-11	4	Zheng Yenyou	NBY	Common Stock	M - Exercise	D			858			1.716
2023-05-15	2023-05-11	4	Zheng Yongxiang	NBY	Common Stock	M - Exercise	D			858			858
2023-05-15	2023-05-11	4	Sit Swan	NBY	Common Stock	M - Exercise	D			858			1.716
2023-05-15	2023-05-11	4	Garlikov Julie	NBY	Common Stock	M - Exercise	D			858			858
2023-05-15	2023-05-11	4	WU MIJIA	NBY	Common Stock	M - Exercise	D			858			1.716
2023-02-24		3	Law Tommy	NBY	Common Stock		D						0
2022-12-07	2022-12-06	4	Kunin Jeffrey	NBY	Common Stock	S - Sale	I		1,8100	-1	-0		0
2022-12-07	2022-12-06	4	Kunin Audrey	NBY	Common Stock	S - Sale	I		1,8100	-1	-0		0
2022-12-05	2022-11-21	4/A	Kunin Jeffrey	NBY	Common Stock	S - Sale	I		2,1049	-5.960	-13		1
2022-12-05	2022-11-21	4/A	Kunin Audrey	NBY	Common Stock	S - Sale	I		2,1049	-5.960	-13		1
2022-11-23	2022-11-21	4	Kunin Jeffrey	NBY	Common Stock	S - Sale	I		2,1049	-5.960	-13		0
2022-11-23	2022-11-21	4	Kunin Audrey	NBY	Common Stock	S - Sale	I		2,1049	-5.960	-13		0
2022-09-16	2022-09-14	4	Hall Justin	NBY	Common Stock	P - Purchase	D		0,1500	10.000	2		83.172
2022-09-16	2022-09-14	4	Kunin Jeffrey	NBY	Common Stock	S - Sale	I		0,1582	-291.368	-46		208.632
2022-09-16	2022-09-14	4	Kunin Audrey	NBY	Common Stock	S - Sale	I		0,1582	-291.368	-46		208.632
2022-05-24	2022-05-21	4	WU MIJIA	NBY	Restricted Stock Units	M - Exercise	D			-30.000		30.000
2022-05-24	2022-05-21	4	WU MIJIA	NBY	Common Stock	M - Exercise	D			30.000			30.000
2022-05-24	2022-05-21	4	Zheng Yenyou	NBY	Restricted Stock Units	M - Exercise	D			-30.000		30.000
2022-05-24	2022-05-21	4	Zheng Yenyou	NBY	Common Stock	M - Exercise	D			30.000			30.000
2022-05-24	2022-05-21	4	Freiman Paul E.	NBY	Restricted Stock Units	M - Exercise	D			-30.000		30.000
2022-05-24	2022-05-21	4	Freiman Paul E.	NBY	Common Stock	M - Exercise	D			30.000			30.000
2022-05-24	2022-05-21	4	Sit Swan	NBY	Restricted Stock Units	M - Exercise	D			-30.000		30.000
2022-05-24	2022-05-21	4	Sit Swan	NBY	Common Stock	M - Exercise	D			30.000			30.000
2022-05-13	2022-05-11	4	Zheng Yenyou	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-05-13	2022-05-11	4	Sit Swan	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-05-13	2022-05-11	4	Zheng Yongxiang	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-05-13	2022-05-11	4	WU MIJIA	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-05-13	2022-05-11	4	Garlikov Julie	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-05-13	2022-05-11	4	Freiman Paul E.	NBY	Restricted Stock Units	A - Award	D			30.000		30.000
2022-02-10		3	Zheng Yongxiang	NBY	Common Stock		D						0
2022-02-03		3	Garlikov Julie	NBY	Common Stock		D						0
2021-12-07	2021-12-03	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4625	101.650	47		500.000
2021-12-07	2021-12-03	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4625	101.650	47		500.000
2021-12-06	2021-12-06	4	Hall Justin	NBY	Common Stock	P - Purchase	D		0,4300	69.767	30		73.172
2021-12-06	2021-12-02	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4760	262.369	125		398.350
2021-12-06	2021-12-06	4	Jones Andrew D.	NBY	Common Stock	P - Purchase	D		0,4400	36.765	16		127.461
2021-12-06	2021-12-03	4	Jones Andrew D.	NBY	Common Stock	P - Purchase	D		0,4400	8.690	4		90.696
2021-12-06	2021-12-02	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4760	262.369	125		398.350
2021-12-03	2021-12-01	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4900	14.848	7		135.981
2021-12-03	2021-12-01	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4900	14.848	7		135.981
2021-12-02	2021-11-30	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4600	30.000	14		121.133
2021-12-02	2021-11-30	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4600	30.000	14		121.133
2021-11-24	2021-11-23	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4592	66.133	30		91.133
2021-11-24	2021-11-22	4	Kunin Jeffrey	NBY	Common Stock	P - Purchase	I		0,4600	25.000	12		25.000
2021-11-24	2021-11-23	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4592	66.133	30		91.133
2021-11-24	2021-11-22	4	Kunin Audrey	NBY	Common Stock	P - Purchase	I		0,4600	25.000	12		25.000
2021-11-17		3	Kunin Jeffrey	NBY	Common Stock		D						0
2021-11-17		3	Kunin Audrey	NBY	Common Stock		D						0
2021-05-25	2021-05-21	4	Zheng Yenyou	NBY	Restricted Stock Unit	A - Award	D			30.000		30.000
2021-05-25	2021-05-21	4	Li Xinzhou	NBY	Restricted Stock Unit	A - Award	D			30.000		30.000
2021-05-25	2021-05-21	4	Sit Swan	NBY	Restricted Stock Unit	A - Award	D			30.000		30.000
2021-05-25	2021-05-21	4	WU MIJIA	NBY	Restricted Stock Unit	A - Award	D			30.000		30.000
2021-05-25	2021-05-21	4	Freiman Paul E.	NBY	Restricted Stock Unit	A - Award	D			30.000		30.000
2021-05-07	2021-05-04	4	Jones Andrew D.	NBY	Common Stock	F - Taxes	D		0,7928	-77.994	-62		82.006
2020-08-24	2020-08-20	4	Hall Justin	NBY	Stock Option (right to buy)	A - Award	D	0,99		350.000		350.000
2020-08-24	2020-08-20	4	Jones Andrew D.	NBY	Stock Option (right to buy)	A - Award	D	0,99		25.000		25.000
2020-08-24	2020-08-20	4	Xu Wang	NBY	Stock Option (right to buy)	A - Award	D	0,99		75.000		75.000
2020-08-19	2020-08-17	4	WU MIJIA	NBY	Stock Option (right to buy)	X - Other	D	0,30		-20.000		0
2020-08-19	2020-08-17	4	WU MIJIA	NBY	Common stock	S - Sale	D		1,3500	-20.000	-27		0
2020-08-19	2020-08-17	4	WU MIJIA	NBY	Common stock	A - Award	D		0,3000	20.000	6		20.000
2020-08-04	2020-08-01	4	Fu Jian Ping	NBY	Common Stock	S - Sale	D		1,2300	-1.302.350	-1.602		4.000.000
2020-05-29	2020-05-26	4	Sit Swan	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-29	2020-05-26	4	Freiman Paul E.	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-29	2020-05-26	4	Wang Xiaopei	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-29	2020-05-26	4	Li Xinzhou	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-29	2020-05-26	4	Zheng Yenyou	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-29	2020-05-26	4	WU MIJIA	NBY	Stock option (right to buy)	A - Award	D	0,89		20.000		20.000
2020-05-13		3	Jones Andrew D.	NBY	Common Stock		D						320.000
2020-05-13		3	Jones Andrew D.	NBY	Common Stock		D						320.000
2020-05-13		3	Jones Andrew D.	NBY	Common Stock		D						320.000
2020-03-19		3	Xu Wang By Spouse	NBY	Common Stock		I						42.000
2020-03-19		3	Xu Wang By Spouse	NBY	Common Stock		I						42.000
2020-03-19		3	Xu Wang By Spouse	NBY	Common Stock		I						42.000
2020-01-28		3	Sit Swan	NBY	Common Stock		D						0
2019-12-18		3	Wang Xiaopei	NBY	Common Stock		D						0
2019-10-30	2019-05-30	4	Zavodnick Todd Erik	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-10-28	2019-06-10	4/A	Hall Justin	NBY	Stock Option (right to buy)	X - Other	D	2,02		-47.500		0
2019-10-28	2019-06-10	4/A	Hall Justin	NBY	Common Stock	S - Sale	D		3,0300	-47.500	-144		3.405
2019-10-28	2019-06-10	4/A	Hall Justin	NBY	Common Stock	A - Award	D		2,0200	47.500	96		50.905
2019-10-28	2019-06-11	4/A	Raleigh Jason Philip	NBY	Stock Option (right to buy)	X - Other	D	2,35		-9.750		0
2019-10-28	2019-06-11	4/A	Raleigh Jason Philip	NBY	Common Stock	S - Sale	D		3,7500	-9.750	-37		0
2019-10-28	2019-06-11	4/A	Raleigh Jason Philip	NBY	Common Stock	A - Award	D		2,3500	9.750	23		9.750
2019-10-28	2019-06-10	4/A	Raleigh Jason Philip	NBY	Stock Option (right to buy)	X - Other	D	2,20		-23.405		0
2019-10-28	2019-06-10	4/A	Raleigh Jason Philip	NBY	Common Stock	S - Sale	D		3,0000	-23.405	-70		0
2019-10-28	2019-06-10	4/A	Raleigh Jason Philip	NBY	Common Stock	A - Award	D		2,2000	23.405	51		23.405
2019-10-28	2019-05-30	4	Freiman Paul E.	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-10-28	2019-05-30	4	SIECZKAREK MARK M	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-10-28	2019-05-30	4	Maderis Gail J	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-10-28	2019-05-30	4	WU MIJIA	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-10-28	2019-05-30	4	Li Xinzhou	NBY	Stock option (right to buy)	A - Award	D	0,30		20.000		20.000
2019-09-30		3	Zheng Yenyou	NBY	Common Stock		D						0
2019-08-06	2019-07-30	4	SIECZKAREK MARK M	NBY	Common Stock	A - Award	D			167.938			1.156.883
2019-06-13	2019-06-11	4	Fu Jian Ping	NBY	common stock	S - Sale	D		3,8400	-380.954	-1.463		5.302.350
2019-06-13	2019-06-11	4	Pioneer Pharma (Hong Kong) Co Ltd	NBY	Common Stock	S - Sale	D		4,0400	-24.326	-98		5.188.421
2019-06-13	2019-06-11	4	WU MIJIA Spouse	NBY	Common Stock	S - Sale	I		4,0400	-15.873	-64		0
2019-06-13	2019-06-10	4	WU MIJIA	NBY	Common Stock	S - Sale	D		2,0300	-47.619	-97		0
2019-06-12	2019-06-11	4	Raleigh Jason Philip	NBY	stock option	X - Other	D	2,35		-9.750		0
2019-06-12	2019-06-10	4	Raleigh Jason Philip	NBY	stock option	X - Other	D	2,20		-23.405		0
2019-06-12	2019-06-10	4	Hall Justin	NBY	stock option	X - Other	D	2,02		-47.500		0
2019-03-26		3	Raleigh Jason Philip	NBY	Common Stock		D						0
2018-10-11	2018-10-09	4	McGovern John Joseph	NBY	Stock option (right to buy)	A - Award	D	1,45		250.000		440.000
2018-06-04	2018-05-31	4	Zavodnick Todd Erik	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		53.698
2018-06-04	2018-05-31	4	WU MIJIA	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		35.244
2018-06-04	2018-05-31	4	Maderis Gail J	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		84.213
2018-06-04	2018-05-31	4	Ma Yonghao	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		43.629
2018-06-04	2018-05-31	4	Li Xinzhou	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		25.248
2018-06-04	2018-05-31	4	Liu Yanbin	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		20.000
2018-06-04	2018-05-31	4	Freiman Paul E.	NBY	Stock Option (right to buy)	A - Award	D	2,20		20.000		62.697
2018-06-01	2018-05-31	4	Hall Justin	NBY	Stock Option (right to buy)	A - Award	D	2,20		190.000		345.710
2018-06-01	2018-05-31	4	McGovern John Joseph	NBY	Stock Option (right to buy)	A - Award	D	2,20		90.000		190.000
2018-05-15		3	Liu Yanbin	NBY	Common Stock		D						0
2018-01-19	2017-01-03	4/A	Ma Yonghao	NBY	stock option (right to buy)	A - Award	D	3,24		20.326		23.629
2018-01-08		3	STUART LEWIS J	NBY	Common Stock		D						0
2018-01-08	2017-12-14	4	STUART LEWIS J	NBY	Restricted Stock Unit	A - Award	D	3,42		10.000		10.000
2018-01-08	2017-12-14	4	STUART LEWIS J	NBY	stock option (right to buy)	A - Award	D	3,42		100.000		100.000
2017-09-18	2017-09-14	4	Hall Justin	NBY	stock option	X - Other	D	2,78		-20.000		278.160
2017-08-01		3	McGovern John Joseph	NBY	Common Stock		D						0
2017-08-01	2017-07-17	4	McGovern John Joseph	NBY	Stock option (right to buy)	A - Award	D	3,80		100.000		100.000
2017-07-07	2017-07-03	4	Li Xinzhou	NBY	stock option (right to buy)	A - Award	D	3,75		5.248		5.248
2017-06-06	2017-06-02	4	SIECZKAREK MARK M	NBY	stock option (right to buy)	A - Award	D	2,35		250.000		250.000
2017-01-26	2017-01-25	4	SIECZKAREK MARK M	NBY	stock option (right to buy)	A - Award	D	3,60		238.609		936.857
2017-01-26	2017-01-25	4	PAULSON THOMAS J	NBY	stock option (right to buy)	A - Award	D	3,60		116.000		310.788
2017-01-26	2017-01-25	4	Hall Justin	NBY	stock option (right to buy)	A - Award	D	3,60		143.000		278.160
2017-01-04	2017-01-03	4	Freiman Paul E.	NBY	stock option (right to buy)	A - Award	D	3,24		25.916		67.097
2017-01-04	2017-01-03	4	Freiman Paul E.	NBY	stock option (right to buy)	A - Award	D	3,24		25.916		67.097
2017-01-04	2017-01-03	4	Maderis Gail J	NBY	stock option (right to buy)	A - Award	D	3,24		23.883		59.769
2017-01-04	2017-01-03	4	Zavodnick Todd Erik	NBY	stock option (right to buy)	A - Award	D	3,24		22.359		33.699
2017-01-04	2017-01-03	4	WU MIJIA	NBY	stock option (right to buy)	A - Award	D	3,24		15.245		15.245
2017-01-04	2017-01-03	4	LIU XIAOYAN	NBY	stock option (right to buy)	A - Award	D	3,24		15.245		15.245
2017-01-04	2017-01-03	4	Ma Yonghao	NBY	stock option (right to buy)	A - Award	D	3,24		33.699		37.002
2016-10-11	2016-10-11	4	Fu Jian Ping	NBY	Common Stock	X - Other	D		3,1500	126.985	400		3.983.304
2016-10-04	2016-10-03	4/A	Zavodnick Todd Erik	NBY	Stock Option (right to buy)	A - Award	D	3,99		247		11.367
2016-10-04	2016-10-03	4	Zavodnick Todd Erik	NBY	Stock Option (right to buy)	A - Award	D	3,99		3.303		14.396
2016-10-04	2016-10-03	4	Ma Yonghao	NBY	Stock Option (right to buy)	A - Award	D	3,99		3.303		3.303
2016-10-03	2016-09-30	4	SIECZKAREK MARK M	NBY	Common Stock	X - Other	D		1,9100	273.447	522		988.945
2016-10-03	2016-09-30	4	WU MIJIA	NBY	Common Stock	X - Other	D		3,1500	15.873	50		47.619
2016-09-26	2016-09-22	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	X - Other	D		1,8100	181.300	328		3.879.519
2016-09-26	2016-09-22	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	X - Other	D		1,9100	1.308.902	2.500		5.188.421
2016-09-26	2016-09-22	4	Fu Jian Ping	NBY	Common Stock	X - Other	D		1,9100	968.587	1.850		3.856.319
2016-09-01		3	Ma Yonghao	NBY	NBY		D						0
2016-08-02	2016-08-01	4	SIECZKAREK MARK M	NBY	Warrant	A - Award	D	1,91		130.890		273.447
2016-08-02	2016-08-01	4	SIECZKAREK MARK M	NBY	Common Stock	A - Award	D		1,9100	261.780	500		715.498
2016-08-02	2016-08-01	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Warrant	A - Award	D	1,91		654.451		1.490.202
2016-08-02	2016-08-01	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	A - Award	D		1,9100	1.308.901	2.500		3.698.219
2016-07-01	2016-07-01	4	Zavodnick Todd Erik	NBY	stock option (right to buy)	A - Award	D	2,58		11.093		0
2016-06-09	2016-06-06	4	Hall Justin	NBY	stock option (right to buy)	A - Award	D	2,78		130.000		135.160
2016-06-08	2016-06-06	4	SIECZKAREK MARK M	NBY	stock option (right to buy)	A - Award	D	2,78		675.000		698.248
2016-06-08	2016-06-06	4	PAULSON THOMAS J	NBY	stock option (right to buy)	A - Award	D	2,78		160.000		194.788
2016-05-16	2016-05-09	4	Fu Jian Ping	NBY	Warrant	A - Award	D	1,91		968.587		1.095.572
2016-05-16	2016-05-09	4	Fu Jian Ping	NBY	Common Stock	A - Award	D		1,9100	1.937.173	3.700		2.887.732
2016-05-13	2016-05-09	4	SIECZKAREK MARK M	NBY	Common Stock	A - Award	D		1,9100	261.780	500		453.718
2016-05-13	2016-05-09	4	SIECZKAREK MARK M	NBY	Warrant	A - Award	D	1,91		130.890		142.557
2016-05-13	2016-05-09	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Warrant	A - Award	D	1,91		654.451		835.751
2016-05-13	2016-05-09	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	A - Award	D		1,9100	1.308.901	2.500		2.389.318
2016-05-10		3	Zavodnick Todd Erik	NBY	NBY		D						0
2016-03-09	2016-03-09	4	SIECZKAREK MARK M	NBY	Restricted Stock Units	A - Award	D			58.692		58.692
2016-03-09	2016-03-09	4	Hall Justin	NBY	Restricted Stock Unit	A - Award	D			5.000		2.400
2016-03-04		3	Fu Jian Ping	NBY	Common Stock		D						1.901.118
2016-03-04		3	Fu Jian Ping	NBY	Common Stock		D						1.901.118
2016-02-26	2016-02-25	4	SIECZKAREK MARK M	NBY	Common Stock	A - Award	D		1,9100	125.387	239		133.246
2016-02-26	2016-02-25	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	A - Award	D		1,9100	696.590	1.330		1.104.742
2016-02-01		3	LIU XIAOYAN	NBY	No securities are beneficially owned.		D						0
2016-02-01		3	WU MIJIA	NBY	Common Stock		D						63.492
2016-02-01		3	WU MIJIA	NBY	Common Stock		D						63.492
2016-01-08		3	Hall Justin	NBY	Common Stock		D						800
2016-01-08		3	Hall Justin	NBY	Common Stock		D						800
2016-01-06	2016-01-04	4	Radaelli Massimo	NBY	Common Stock (right to buy)	A - Award	D	2,02		600		2.400
2016-01-06	2016-01-04	4	Maderis Gail J	NBY	Stock Option (right to buy)	A - Award	D	2,02		24.777		35.886
2016-01-06	2016-01-04	4	McPherson T. Alex	NBY	Common Stock (right to buy)	A - Award	D	2,02		22.719		44.210
2016-01-06	2016-01-04	4	Freiman Paul E.	NBY	Stock Option (right to buy)	A - Award	D	2,02		26.835		41.181
2016-01-06	2016-01-04	4	SIECZKAREK MARK M	NBY	Stock Option (right to buy)	A - Award	D	2,02		16.032		23.246
2015-10-06	2015-10-05	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	0,27		100.000		474.834
2015-10-06	2015-10-05	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	0,27		150.000		869.675
2015-10-06	2015-10-05	4	PAULSON THOMAS J	NBY	Restricted Stock Unit	A - Award	D			50.000			142.196
2015-10-06	2015-10-05	4	WU ROY J	NBY	Restricted Stock Unit	A - Award	D	0,00		25.000		25.000
2015-10-06	2015-10-05	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	0,27		150.000		614.725
2015-08-21	2015-08-20	4	Najafi Ramin Individual Retirement Account	NBY	Common Stock	P - Purchase	I		0,4400	6.000	3		12.000
2015-08-21	2015-08-19	4	Najafi Ramin Individual Retirement Account	NBY	Common Stock	P - Purchase	I		0,5000	6.000	3		6.000
2015-06-16	2015-06-12	4	SIECZKAREK MARK M	NBY	Stock Option (right to buy)	A - Award	D	0,79		24.128		180.362
2015-04-30	2015-04-14	4/A	Hoon Russell A.	NBY	Common Stock	C - Conversion	D			4.515			34.217
2015-04-15	2015-04-14	4	Hoon Russell A.	NBY	Restricted Stock Unit	A - Award	D			4.515		34.217
2015-03-25	2015-03-23	4	PAULSON THOMAS J	NBY	Restricted Stock Unit	A - Award	D			23.986			92.196
2015-03-25	2015-03-23	4	WU ROY J	NBY	Restricted Stock Unit	A - Award	D			19.296			19.296
2015-03-25	2015-03-23	4	Najafi Ramin Ownership through the Najafi Family Trust	NBY	Restricted Stock Unit	A - Award	I			46.033			3.437.699
2015-03-05	2015-03-03	4	SIECZKAREK MARK M	NBY	Warrant	P - Purchase	D	0,65	0,6500	124.999	81	291.665
2015-03-05	2015-03-03	4	SIECZKAREK MARK M	NBY	Warrant	P - Purchase	D	0,60	0,6000	166.666	100	291.665
2015-03-05	2015-03-03	4	SIECZKAREK MARK M	NBY	Common Stock	P - Purchase	D		0,6000	166.666	100		196.466
2015-03-05	2015-03-03	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Warrant	P - Purchase	D	0,65	0,6500	1.942.500	1.263	4.532.500
2015-03-05	2015-03-03	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Warrant	P - Purchase	D	0,60	0,6000	2.590.000	1.554	4.532.500
2015-03-05	2015-03-03	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	P - Purchase	D		0,6000	2.590.000	1.554		9.595.656
2015-03-05	2015-03-03	4	Najafi Ramin Ownership through the Najafi Family Trust	NBY	Warrant	P - Purchase	I	0,65	0,6500	124.999	81	291.665
2015-03-05	2015-03-03	4	Najafi Ramin Ownership through the Najafi Family Trust	NBY	Warrant	P - Purchase	I	0,60	0,6000	166.666	100	291.665
2015-03-05	2015-03-03	4	Najafi Ramin Ownership through the Najafi Family Trust	NBY	Common Stock	P - Purchase	I		0,6000	166.666	100		3.391.666
2015-01-06	2015-01-02	4	Cashion Charles	NBY	Stock Option (right to buy)	A - Award	D	0,64		69.368		377.156
2015-01-06	2015-01-02	4	McPherson T. Alex	NBY	Stock Option (right to buy)	A - Award	D	0,64		144.444		537.279
2015-01-06	2015-01-02	4	Radaelli Massimo	NBY	Stock Option (right to buy)	A - Award	D	0,64		15.000		45.000
2015-01-06	2015-01-02	4	SIECZKAREK MARK M	NBY	Stock Option (right to buy)	A - Award	D	0,64		92.667		156.234
2015-01-06	2015-01-02	4	Maderis Gail J	NBY	Stock Option (right to buy)	A - Award	D	0,64		121.144		277.726
2015-01-06	2015-01-02	4	Freiman Paul E.	NBY	Stock Option (right to buy)	A - Award	D	0,64		121.144		358.654
2015-01-06	2015-01-02	4	Wicks Tony D.S.	NBY	Stock Option (right to buy)	A - Award	D	0,64		15.000		301.016
2014-12-24		3	Hoon Russell A.	NBY	Restricted Stock Unit		D						59.404
2014-12-24		3	Hoon Russell A.	NBY	Restricted Stock Unit		D						59.404
2014-12-16	2014-12-12	4	Stroman David W.	NBY	Common Stock	P - Purchase	D		0,6600	10.000	7		23.000
2014-12-15	2014-12-12	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		0,6500	50.000	32		0
2014-12-15	2014-12-12	4	PAULSON THOMAS J	NBY	Common Stock	P - Purchase	D		0,6800	10.000	7		68.210
2014-12-11	2014-12-09	4	PAULSON THOMAS J	NBY	Common Stock	P - Purchase	D		0,6700	10.000	7		58.210
2014-12-11	2014-12-11	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		0,6000	20.000	12		3.175.000
2014-12-08	2014-12-05	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		0,6500	25.000	16		3.155.000
2014-12-04	2014-12-02	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		0,7100	18.000	13		3.130.000
2014-12-04	2014-12-02	4	Wicks Tony D.S.	NBY	Common Stock	S - Sale	D		0,7000	-20.000	-14		0
2014-12-03	2014-12-01	4	Wicks Tony D.S.	NBY	Common Stock	S - Sale	D		0,6900	-10.000	-7		213.680
2014-09-30	2014-09-26	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	0,75		50.000		374.834
2014-09-30	2014-09-26	4	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	0,75		90.000		1.015.032
2014-09-30	2014-09-26	4	Bley Keith R	NBY	Option (right to buy)	A - Award	D	0,75		50.000		258.120
2014-09-30	2014-09-26	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	0,75		60.000		719.675
2014-09-30	2014-09-26	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	0,75		50.000		464.725
2014-06-05	2014-06-04	4	SIECZKAREK MARK M	NBY	Common Stock	P - Purchase	D		0,8900	4.800	4		29.800
2014-06-04	2014-06-02	4	Najafi Ramin Najafi Family Trust	NBY	Common Stock	G - Gift	I			-5.500			3.112.000
2014-05-21	2014-05-19	4	SIECZKAREK MARK M	NBY	Common Stock	P - Purchase	D		0,8800	25.000	22		25.000
2014-05-14	2014-05-09	4	China Pioneer Pharma Holdings Ltd	NBY	Common Stock	P - Purchase	D		0,9900	318.828	316		426.984
2014-05-14	2014-05-12	4	China Pioneer Pharma Holdings Ltd	NBY	Common Stock	P - Purchase	D		0,9900	116.107	115		543.091
2014-05-14	2014-05-13	4	China Pioneer Pharma Holdings Ltd	NBY	Common Stock	P - Purchase	D		0,9900	65.065	64		608.156
2014-04-17	2014-04-15	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	1,00		7.823		414.725
2014-04-17	2014-04-15	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,00		9.866		699.675
2014-04-17	2014-04-15	4	Bley Keith R	NBY	Option (right to buy)	A - Award	D	1,00		7.120		208.120
2014-04-17	2014-04-15	4	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	1,00		10.180		925.032
2014-04-17	2014-04-15	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	1,00		5.011		324.834
2014-04-14	2014-04-14	4	Wicks Tony D.S.	NBY	Option (right to buy)	M - Exercise	D	0,56		-52.000		234.068
2014-04-14	2014-04-14	4	Wicks Tony D.S.	NBY	Common Stock	M - Exercise	D		0,5600	52.000	29		213.690
2014-03-21	2014-03-17	4	Dailley Anthony	NBY	Option (right to buy)	M - Exercise	D	0,56		-9.000		191.967
2014-03-21	2014-03-17	4	Dailley Anthony	NBY	Common Stock	M - Exercise	D		0,5600	9.000	5		285.259
2014-01-31	2014-01-30	4	SIECZKAREK MARK M	NBY	Option (right to buy)	A - Award	D	1,14		33.567		63.567
2014-01-31	2014-01-30	4	Wicks Tony D.S.	NBY	Option (right to buy)	A - Award	D	1,14		14.919		286.068
2014-01-31	2014-01-30	4	Tufts Robert R.	NBY	Option (right to buy)	A - Award	D	1,14		30.583		191.468
2014-01-31	2014-01-30	4	Cashion Charles	NBY	Option (right to buy)	A - Award	D	1,14		31.329		307.788
2014-01-31	2014-01-30	4	McPherson T. Alex	NBY	Option (right to buy)	A - Award	D	1,14		86.528		382.335
2014-01-31	2014-01-30	4	Maderis Gail J	NBY	Option (right to buy)	A - Award	D	1,14		61.167		267.631
2014-01-09	2014-01-09	4	SIECZKAREK MARK M	NBY	Option (right to buy)	A - Award	D	1,25		30.000		30.000
2014-01-09	2014-01-02	4	Wicks Tony D.S.	NBY	Option (right to buy)	A - Award	D	1,29		15.000		271.149
2014-01-09	2014-01-02	4	Freiman Paul E.	NBY	Option (right to buy)	A - Award	D	1,29		15.000		237.510
2014-01-09	2014-01-02	4	Tufts Robert R.	NBY	Option (right to buy)	A - Award	D	1,29		15.000		160.885
2014-01-09	2014-01-02	4	Dailley Anthony	NBY	Option (right to buy)	A - Award	D	1,29		15.000		203.217
2014-01-09	2014-01-02	4	Cashion Charles	NBY	Option (right to buy)	A - Award	D	1,29		15.000		276.459
2014-01-09	2014-01-02	4	McPherson T. Alex	NBY	Option (right to buy)	A - Award	D	1,29		15.000		295.807
2014-01-09	2014-01-09	4	Radaelli Massimo	NBY	Option (right to buy)	A - Award	D	1,25		30.000		30.000
2014-01-09	2014-01-02	4	Maderis Gail J	NBY	Option (right to buy)	A - Award	D	1,29		15.000		206.464
2013-12-04	2013-12-02	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	D	1,50		-1.200.000		0
2013-12-04	2013-12-02	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	D	1,50		-800.000		0
2013-12-04	2013-12-02	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	P - Purchase	D		1,1400	5.000.000	5.700		7.005.656
2013-12-04	2013-12-02	4	China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	I	1,50		-1.200.000		0
2013-12-04	2013-12-02	4	China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	I	1,50		-800.000		0
2013-12-04	2013-12-02	4	China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	P - Purchase	I		1,1400	5.000.000	5.700		7.005.656
2013-12-04	2013-12-02	4	Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	I	1,50		-1.200.000		0
2013-12-04	2013-12-02	4	Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock Purchase Warrant (Right to Buy)	H - Other	I	1,50		-800.000		0
2013-12-04	2013-12-02	4	Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	P - Purchase	I		1,1400	5.000.000	5.700		7.005.656
2013-12-02	2013-07-22	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	J - Other	D			3.913			2.005.656
2013-12-02	2013-04-29	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	J - Other	D			1.743			2.001.743
2013-12-02	2013-04-29	4	Li Xinzhou By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	J - Other	I			1.743			2.001.743
2013-12-02	2013-09-20	4	Li Xinzhou	NBY	Common Stock	S - Sale	D		1,8749	-120.000	-225		0
2013-12-02		3	China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock		I						2.001.743
2013-12-02	2013-11-14	4	China Pioneer Pharma Holdings Ltd	NBY	Common Stock	P - Purchase	D		1,0200	108.156	110		108.156
2013-12-02	2013-07-22	4	China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	J - Other	I			3.913			2.005.656
2013-12-02		3	Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock		I						2.001.743
2013-12-02	2013-07-22	4	Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	J - Other	I			3.913			2.005.656
2013-10-29	2013-10-28	4	PAULSON THOMAS J	NBY	Common Stock	F - Taxes	D		1,7500	-3.645	-6		63.855
2013-10-29	2013-10-28	4	Najafi Ramin	NBY	Common Stock	F - Taxes	D		1,7500	-4.557	-8		100.195
2013-10-02	2013-09-26	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,71		-110.000		689.809
2013-10-02	2013-09-26	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	1,71		62.000		406.902
2013-10-02	2013-09-26	4	Bley Keith R	NBY	Option (right to buy)	A - Award	D	1,71		51.000		201.000
2013-10-02	2013-09-26	4	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	1,71		-150.000		914.852
2013-10-02	2013-09-26	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	1,71		-62.000		319.823
2013-03-06	2013-03-05	4	Bley Keith R	NBY	Options (right to buy)	A - Award	D	1,15		150.000		150.000
2013-02-01	2013-01-30	4	Wicks Tony D.S.	NBY	Options (right to buy)	A - Award	D	1,29		19.603		256.149
2013-02-01	2013-01-30	4	Cashion Charles	NBY	Option (right to buy)	A - Award	D	1,29		19.603		261.459
2013-02-01	2013-01-30	4	McPherson T. Alex	NBY	option (right to buy)	A - Award	D	1,29		39.205		280.807
2013-02-01	2013-01-30	4	Maderis Gail J	NBY	Option (right to buy)	A - Award	D	1,29		39.205		191.464
2013-01-15	2013-01-02	4	Wicks Tony D.S.	NBY	Option (right to buy)	A - Award	D	1,13		15.000		236.546
2013-01-15	2013-01-02	4	Freiman Paul E.	NBY	Option (right to buy)	A - Award	D	1,13		15.000		222.510
2013-01-15	2013-01-02	4	Tufts Robert R.	NBY	Option (right to buy)	A - Award	D	1,13		15.000		145.885
2013-01-15	2013-01-02	4	Dailley Anthony	NBY	Option (right to buy)	A - Award	D	1,13		15.000		188.217
2013-01-15	2013-01-02	4	Cashion Charles	NBY	Option (right to buy)	A - Award	D	1,13		15.000		241.856
2013-01-15	2013-01-02	4	McPherson T. Alex	NBY	Option (right to buy)	A - Award	D	1,13		15.000		241.602
2013-01-15	2013-01-02	4	Maderis Gail J	NBY	Option (right to buy)	A - Award	D	1,13		15.000		152.259
2013-01-14	2013-01-10	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,13		25.000		579.809
2013-01-14	2013-01-10	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	1,13		25.000		344.902
2013-01-14	2013-01-10	4	Khosrovi Behzad	NBY	Option (right to buy)	A - Award	D	1,13		25.000		536.283
2013-01-14	2013-01-10	4	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	1,13		85.000		764.852
2013-01-14	2013-01-20	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	1,13		25.000		257.823
2013-01-03	2012-12-11	4	Li Xinzhou	NBY	Common Stock	P - Purchase	D		1,2000	120.000	144		2.120.000
2013-01-02	2012-09-13	4	Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq	NBY	Warrant	P - Purchase	I	1,50	1,5000	800.000	1.200	800.000
2013-01-02	2012-09-13	4	Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu	NBY	Common Stock	P - Purchase	I		1,2500	800.000	1.000		800.000
2013-01-02		3	Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu	NBY	Common Stock		I						800.000
2013-01-02	2012-10-31	4	Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq	NBY	Warrant	P - Purchase	I	1,50	1,5000	1.200.000	1.800	2.000.000
2013-01-02	2012-10-31	4	Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu	NBY	Common Stock	P - Purchase	I		1,2500	1.200.000	1.500		2.000.000
2012-12-10	2012-12-06	4	PAULSON THOMAS J	NBY	warrant to purchase Common Stock	P - Purchase	D	1,50	0,0100	7.500	0	7.500
2012-12-10	2012-12-06	4	PAULSON THOMAS J	NBY	Common Stock	P - Purchase	D		1,2400	10.000	12		63.855
2012-12-10	2012-12-06	4	Najafi Ramin	NBY	Warrants to Purchase Common Shares	P - Purchase	D	1,50	0,0100	15.000	0	15.000
2012-12-10	2012-12-06	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		1,2400	20.000	25		100.195
2012-12-10	2012-12-06	4	Stroman David W.	NBY	Warrants to purchase Common Stock	P - Purchase	D	1,50	0,0100	7.500	0	7.500
2012-12-10	2012-12-06	4	Stroman David W.	NBY	Common Stock	P - Purchase	D		1,2400	10.000	12		22.000
2012-12-04	2012-10-27	4	PAULSON THOMAS J	NBY	Common Stock	F - Taxes	D		1,3100	-3.645	-5		53.855
2012-12-04	2012-10-27	4	Najafi Ramin	NBY	Common Stock	F - Taxes	D		1,3100	-4.557	-6		80.195
2012-11-20	2012-10-31	4	NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma Co.	NBY	Warrant	P - Purchase	I	1,50	1,5000	1.200.000	1.800	2.000.000
2012-11-20	2012-10-31	4	NAQU AREA PIONEER PHARMA CO., LTD. Shares are held directly by Pioneer Pharma (Singapore) Pte. Ltd. Pioneer Pharma (Singapore) Pte. Lt	NBY	Common Stock	P - Purchase	I		1,2500	1.200.000	1.500		2.000.000
2012-11-20		3	NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. is a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma C	NBY	Common Stock		I						800.000
2012-11-05	2012-10-31	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Warrant	P - Purchase	D	1,50	1,5000	1.200.000	1.800	2.000.000
2012-11-05	2012-10-31	4	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock	P - Purchase	D		1,2500	1.200.000	1.500		2.000.000
2012-11-05		3	Pioneer Pharma (Singapore) Pte. Ltd.	NBY	Common Stock		D						800.000
2012-11-01	2012-09-26	4/A	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,22		25.000		554.809
2012-11-01	2012-09-26	4/A	Stroman David W.	NBY	Option (right to buy)	A - Award	D	1,22		25.000		232.823
2012-11-01	2012-09-26	4/A	WU ROY J	NBY	Option (right to buy)	A - Award	D	1,22		25.000		319.902
2012-11-01	2012-09-26	4/A	Khosrovi Behzad	NBY	Option (right to buy)	A - Award	D	1,22		25.000		511.283
2012-11-01	2012-09-26	4/A	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	1,22		65.000		679.852
2012-11-01	2012-09-27	4	Tufts Robert R.	NBY	Option (right to buy)	M - Exercise	D	0,56	0,5600	-28.500	-16	0
2012-11-01	2012-09-27	4	Tufts Robert R. ROBERT R TUFTS & JOYCE A TUFTS TR ROBERT & JOYCE TUFTS TRUST UA 09/18/87	NBY	Common Stock	M - Exercise	I		0,5600	28.500	16		348.408
2012-10-12	2012-10-10	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,29		25.000		554.809
2012-10-12	2012-10-10	4	WU ROY J	NBY	Option (right to buy)	A - Award	D	1,29		25.000		319.902
2012-10-12	2012-10-10	4	Najafi Ramin	NBY	Option (right to buy)	A - Award	D	1,29		65.000		679.852
2012-10-12	2012-10-10	4	Khosrovi Behzad	NBY	Option (right to buy)	A - Award	D	1,29		25.000		511.283
2012-10-12	2012-10-10	4	Stroman David W.	NBY	Option (right to buy)	A - Award	D	1,29		25.000		232.823
2012-05-31	2012-05-30	4	PAULSON THOMAS J	NBY	Common Stock	P - Purchase	D		0,9364	10.000	9		17.500
2012-05-30	2012-05-29	4	Najafi Ramin	NBY	Common	P - Purchase	D		0,9600	2.000	2		34.752
2012-05-30	2012-05-29	4	Najafi Ramin	NBY	Common	P - Purchase	D		0,9590	4.000	4		32.752
2012-05-29	2012-05-25	4	Najafi Ramin	NBY	Common Stock	P - Purchase	D		0,9900	3.500	3		28.752
2012-04-02	2007-10-25	5/A	Stroman David W.	NBY	Common Stock	P - Purchase	D		4,0000	2.000	8		2.000
2012-02-23	2012-02-17	4	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,44		54.709		529.809
2012-02-23	2012-02-17	4	WU ROY J	NBY	Option (Right to Buy)	A - Award	D	1,44		48.902		294.902
2012-02-23	2012-02-17	4	Khosrovi Behzad	NBY	Option (right to buy)	A - Award	D	1,44		52.083		486.283
2012-02-23	2012-02-17	4	Najafi Ramin	NBY	Option (right to purchase)	A - Award	D	1,44		96.652		614.852
2012-02-23	2012-02-17	4	Stroman David W.	NBY	Option (Right to Buy)	A - Award	D	1,44		7.823		207.823
2012-02-13	2011-06-16	5	Stroman David W.	NBY	Common Stock	P - Purchase	D		1,0100	10.000	10		10.000
2012-01-05	2012-01-03	4	Wicks Tony D.S.	NBY	Option (right to buy)	A - Award	D	1,33		66.230		66.230
2012-01-05	2011-12-29	4	Freiman Paul E.	NBY	Option (right to buy)	X - Other	D	0,20	0,2000	-30.000	-6	30.000
2012-01-05	2011-12-29	4	Freiman Paul E. PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TTEES PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TR U/A DTD 5	NBY	Common Stock	X - Other	I		0,2000	30.000	6		45.137
2012-01-05	2012-01-03	4	Tufts Robert R.	NBY	Option (right to buy)	A - Award	D	1,33		67.510		67.510
2012-01-05	2012-01-03	4	Freiman Paul E.	NBY	Option(right to buy)	A - Award	D	1,33		67.510		67.510
2012-01-05	2012-01-03	4	Dailley Anthony	NBY	Option (right to buy)	A - Award	D	1,33		66.230		66.230
2012-01-05	2012-01-03	4	Cashion Charles	NBY	Option (right to buy)	A - Award	D	1,33		68.791		68.791
2012-01-05	2012-01-03	4	McPherson T. Alex	NBY	Option (right to buy)	A - Award	D	1,33		79.037		79.037
2012-01-05	2012-01-03	4	Maderis Gail J	NBY	Option (right to buy)	A - Award	D	1,33		67.510		67.510
2011-02-01	2008-09-05	4/A	Scott Colin	NBY	Option (right to buy)	A - Award	D	1,95		35.400		72.900
2011-02-01	2008-09-05	4/A	PAULSON THOMAS J	NBY	Option (right to buy)	A - Award	D	1,95		44.400		244.400
2011-02-01	2008-09-05	4/A	Khosrovi Behzad	NBY	Option (right to buy)	A - Award	D	1,95		35.400		72.900
2011-01-27	2009-01-14	4/A	McPherson T. Alex	NBY	Common Stock	A - Award	D			9.084			28.558
2011-01-27	2009-01-14	4/A	Cashion Charles By the Charles J. Cashion and Martha Diane Cashion Trust u/d/t dated July 27, 1998	NBY	Common Stock	A - Award	I			8.239			18.495
2011-01-18	2008-08-25	4/A	Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987	NBY	Common Stock	A - Award	I			1.353			204.056
2011-01-18	2008-08-25	4/A	Dailley Anthony By the Anthony & Terry Dailley Trust, u/a/d 1991	NBY	Common Stock	A - Award	I			1.353			146.047
2011-01-18	2008-08-25	4/A	Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust dated 5/24/95	NBY	Common Stock	A - Award	I			1.353			33.412
2011-01-18	2008-08-25	4/A	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Common Stock	A - Award	I			1.353			140.657
2011-01-05	2011-01-03	4	Wicks Tony D.S.	NBY	Option (right to buy)	A - Award	D	1,67		15.000		15.000
2011-01-05	2011-01-03	4	Freiman Paul E.	NBY	Option (right to buy)	A - Award	D	1,67		15.000		15.000
2011-01-05	2011-01-03	4	Tufts Robert R.	NBY	Option (right to buy)	A - Award	D	1,67		27.375		27.375
2011-01-05	2011-01-03	4	Dailley Anthony	NBY	Option (right to buy)	A - Award	D	1,67		15.000		15.000
2009-10-15		3	Anderson Mark Brian	NBY	Common Stock		D						100
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Series C Preferred Stock	C - Conversion	I	0,00		-17.647		0
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Series B Preferred Stock	C - Conversion	I	0,00		-32.000		0
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan	NBY	Series B Preferred Stock	C - Conversion	I	0,00		-10.638		0
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Series A Preferred Stock	C - Conversion	I	0,00		-57.143		0
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Common Stock	C - Conversion	I			-8.823			138.423
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Common Stock	C - Conversion	I			16.000			129.600
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan	NBY	Common Stock	C - Conversion	I			5.319			7.180
2007-10-31	2007-10-31	4	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Common Stock	C - Conversion	I			28.572			113.600
2007-10-31	2007-10-31	4	Khosrovi Behzad	NBY	Series B Preferred Stock	C - Conversion	D	0,00		-200.000		0
2007-10-31	2007-10-31	4	Khosrovi Behzad	NBY	Common Stock	C - Conversion	D			100.000			135.000
2007-10-31	2007-10-31	4	McPherson T. Alex	NBY	Series D Preferred Stock	C - Conversion	D	0,00		-16.666		0
2007-10-31	2007-10-31	4	McPherson T. Alex	NBY	Common Stock	C - Conversion	D			8.333			8.333
2007-10-31	2007-10-31	4	Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987	NBY	Series A Preferred Stock	C - Conversion	I	0,00		-142.857		0
2007-10-31	2007-10-31	4	Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987	NBY	Common Stock	P - Purchase	I		4,0000	67.500	270		194.499
2007-10-31	2007-10-31	4	Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987	NBY	Common Stock	C - Conversion	I			71.428			126.999
2007-10-31	2007-10-31	4	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Series B Preferred Stock	C - Conversion	I	0,00		-30.000		0
2007-10-31	2007-10-31	4	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Series A Preferred Stock	C - Conversion	I	0,00		-71.429		0
2007-10-31	2007-10-31	4	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Common Stock	C - Conversion	I			15.000			130.964
2007-10-31	2007-10-31	4	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Common Stock	C - Conversion	I			35.714			115.964
2007-10-24		3	Najafi Family Trust dated September 13, 2006 By the Najafi Family Trust dated September 13, 2006	NBY	Common Stock		I						3.117.500
2007-10-24		3	Khosrovi Behzad	NBY	Common Stock		D						35.000
2007-10-24		3	Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan	NBY	Common Stock		I						1.861
2007-10-24		3	Dailley Anthony	NBY	Common Stock		D						75.000
2007-10-24		3	Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991	NBY	Common Stock		I						85.028
2007-10-24		3	Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust	NBY	Common Stock		I						25.000
2007-10-24		3	Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987	NBY	Common Stock		I						55.571
2007-10-24		3	Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust	NBY	Common Stock		I						80.250

Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren

Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren

Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)

Umwandlung von Derivaten

Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen

Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere

Schenkung von Wertpapieren durch oder an den Insider

Aktien-Swaps und ähnliche Absicherungstransaktionen

Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)

Eine freiwillig auf Formular 4 gemeldete Transaktion

Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)

SDEV / Stablecoin Development Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5